Small extracellular vesicles have distinct CD81 and CD9 tetraspanin expression profiles in plasma from rheumatoid arthritis patients
Open Access
- 24 February 2023
- journal article
- research article
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 23 (6) , 2867-2875
Abstract
Extracellular vesicles (EVs) are implicated in the pathogenesis of rheumatoid arthritis (RA) but little is known about the composition of specific small EV (sEV) subpopulations. This study aimed to characterize the CD63, CD81 and CD9 tetraspanin profile in the membrane of single EVs in plasma from treatment naïve RA patients and assess potential discrepancies between methotrexate (MTX) responder groups. EVs isolated from plasma were characterized using transmission electron microscopy, and detection of surface markers (CD63, CD81 and CD9) on single EVs was performed on the ExoView platform. All RA patients (N = 8) were newly diagnosed, treatment naïve, females, ACPA positive and former smokers. The controls (N = 5) were matched for age and gender. After three months of MTX treatment, responders (N = 4) were defined as those with ΔDAS28 > 1.2 and DAS28 ≤ 3.2 post-treatment. The isolated EVs were 50–200 nm in size. The RA patients had a higher proportion of both CD9 and CD81 single positive sEVs compared to healthy controls, while there was a decrease in CD81/CD9 double positive sEVs in patients. Stratification of RA patients into MTX responders and non-responders revealed a distinctly higher proportion of CD81 single positive sEVs in the responder group. The proportion of CD81/CD9 double positive sEVs (anti-CD9 captured) was lower in the non-responders, but increased upon 3 months of MTX treatment. Our exploratory study revealed distinct tetraspanin profiles in RA patients suggesting their implication in RA pathophysiology and MTX treatment response.Keywords
Funding Information
- Norges Forskningsråd (301536, 301536)
- University of Oslo
This publication has 36 references indexed in Scilit:
- The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle‐associated immune complexesEMBO Molecular Medicine, 2012
- ADAM‐10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesisArthritis & Rheumatism, 2012
- 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiativeAnnals of the Rheumatic Diseases, 2010
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle ProductionScience, 2010
- ExoCarta: A compendium of exosomal proteins and RNAProteomics, 2009
- Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activityArthritis Research & Therapy, 2009
- The Human Protein Atlas—a tool for pathologyThe Journal of Pathology, 2008
- Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid jointsArthritis & Rheumatism, 2005
- Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritisArthritis & Rheumatism, 2002
- Development and Validation of Response Criteria in Rheumatoid Arthritis: Steps Towards an International Consensus on Prognostic MarkersRheumatology, 1996